REQUEST A DEMO
Total
USD $0.00
Search more companies

Bax Pharma, S.R.O. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Bax Pharma, S.R.O. Profile Updated: October 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Bax Pharma, S.R.O. is an enterprise in Slovakia, with the main office in Bratislava. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The enterprise was incorporated on December 17, 1998. Bax Pharma, S.R.O. currently employs 20 - 24 (2025) people. The latest financial highlights indicate a net sales revenue increase of 54.63% in 2025. Its’ total assets recorded a growth of 35.89%. Bax Pharma, S.R.O.’s net profit margin decreased by 1.93% in 2025.

Headquarters
Leskova, 8
Bratislava; Bratislavsky; Postal Code: 81104

Contact Details: Purchase the Bax Pharma, S.R.O. report to view the information.

Website: http://www.kdispozicii.sk

Basic Information
Total Employees:
Purchase the Bax Pharma, S.R.O. report to view the information.
Registered Capital:
Purchase the Bax Pharma, S.R.O. report to view the information.
Financial Auditors:
Purchase the Bax Pharma, S.R.O. report to view the information.
Incorporation Date:
December 17, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Bax Pharma, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
54.63%
Total Operating Revenue
54.67%
Operating Profit
26.55%
EBITDA
27.92%
Net Profit/Loss for the Period
23.16%
Total Assets
35.89%
Total Equity
-39.6%
Operating Profit Margin
-2.18%
Net Profit Margin
-1.93%
Return on Equity (ROE)
50.87%
Debt / Equity
0.15%
Quick Ratio
-0.33%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?